New Phase 1 Trials to Evaluate LG203003 for Nonalcoholic Steatohepatitis
On March 29, 2022, globally diversified chemical company LG Chem announced via press release that its Investigational New Drug (IND) application was approved by the U.S. Food and Drug Administration…